Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases

Author:   Jawad Laadraoui ,  Bilal El-Mansoury
Publisher:   IGI Global
ISBN:  

9798337313665


Pages:   522
Publication Date:   14 January 2026
Format:   Paperback
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Our Price $475.20 Quantity:  
Add to Cart

Share |

Nanoparticles Agents and Secondary Metabolites in Neurodegenerative Diseases


Overview

Full Product Details

Author:   Jawad Laadraoui ,  Bilal El-Mansoury
Publisher:   IGI Global
Imprint:   Medical Information Science Reference
ISBN:  

9798337313665


Pages:   522
Publication Date:   14 January 2026
Audience:   College/higher education ,  Professional and scholarly ,  Tertiary & Higher Education ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   In Print   Availability explained
This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us.

Table of Contents

Reviews

Author Information

Dr. Jawad Laadraoui is a professor of neurophysiology and neuroscience at the Department of Biology, Faculty of Sciences Ain Chock, Hassan II University of Casablanca, Morocco. His research focuses on neurodegenerative diseases and the effects of natural compounds on brain health, with particular emphasis on the interplay between neuroinflammation, seizure activity, and the therapeutic potential of natural compounds, aiming to develop innovative treatment strategies. Dr. Bilal El-Mansoury is a Professor at the Department of Biology, Faculty of Sciences, Chouaib Doukkali University. He served as a Postdoc Researcher in Neuroscience and Neurology at the Royal College of Surgeons in Ireland, University of Medicine and Health Sciences. His work centers on understanding how glial cells dysfunction contributes to the pathophysiology of hepatic encephalopathy and various neurodegenerative disorders. Dr. El-Mansoury also investigated the role of miRNAs in CDKL5 deficiency disorder, with the aim of identifying novel therapeutic targets for this rare epileptic encephalopathy. In addition to his research, Dr. El-Mansoury is Editor of the Book .

Tab Content 6

Author Website:  

Countries Available

All regions
Latest Reading Guide

RGFEB26

 

Shopping Cart
Your cart is empty
Shopping cart
Mailing List